Table of Content - Vitiligo Drugs Market

Vitiligo is a disease that causes loss of skin colour in patches. The discoloured areas usually get bigger with time. The condition usually affects the skin on any part of the body. It can also affect hair and the inside of the mouth. The colour of hair and skin is determined by melanin. Melanin is a natural skin pigment; skin, eye, and hair color in people and animal depends on type and amount of melanin. Vitiligo occurs, when cells that produce melanin stop functioning. The condition is not life- threatening or transferable. There are two major categories of vitiligo disease such as segmental vitiligo and non-segmental vitiligo. Some of the major symptoms of vitiligo disease includes patchy loss of skin colour, which mostly appears on hands and face. Premature whitening of the hair on your scalp or eyebrows. Loss in the colour inside the mouth. Vitiligo disease can be treated by medications such as calcineurin inhibitors, corticosteroids, Psoralens. Vitiligo disease is also treated by surgery.

Market Dynamics

Agreement and collaboration by major players to develop drug is expected to propel growth of the global vitiligo drug market during the forecast period. For instance, in October 2018, Boston Pharmaceutical announced the agreement with GlaksoSmith Kline for development of phase 1 pipeline drug GSK3183475, a small molecule inhibitor used in treatment of vitiligo and psoriasis.

However, alternative therapies for vitiligo treatment is expected to limit the market growth. For instance, combination therapy of psoralen and light therapy. The treatment combines the use of a plant- derived molecule called psoralen and light therapy for treating vitiligo. The patient is exposed to ultraviolet light after ingesting psoralen. The total span of treatment ranges between 3 weeks to 12 months.

Key features of the study

This report provides in-depth analysis of the global vitiligo drug market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2026-2033, considering 2025 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global lung cancer screening market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Dermavant Sciences, Inc., Incyte Corporation, Aclaris Therapeutics, Inc., Dr. Reddy’s Laboratories Ltd., Bristol- Myers Squibb, Pfizer, Inc., Clinuvel Pharmaceuticals Ltd., Boston Pharmaceuticals, Applied Biology, Inc., Arcutis Biotherapeutics, Villaris Therapeutics, Arrien Pharmaceuticals LLC, and Temprian Therapeutics Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global vitiligo drug market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for vitiligo drug market, research and consulting firms, new entrants, and financial analysts.

Market Segmentation

By Drug Type (Revenue, USD Mn, 2021-2033)
- Marketed Drug
  - Calcineurin Inhibitors
  - Corticosteroids
  - Psoralens
- Pipeline Drug
  - Ruxolitinib (Phase 3)
By Indication Type (Revenue, USD Mn, 2021-2033)
- Segmental Vitiligo
- Non-segmental Vitiligo
By Route of Administration (Revenue, USD Mn, 2021-2033)
- Oral
- Topical
By Distribution Channel (Revenue, USD Mn, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region (Revenue, USD Mn, 2021-2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - Central Africa
  - North Africa
Key Players
- Dermavant Sciences, Inc.
- Incyte Corporation
- Aclaris Therapeutics, Inc.
- Reddy’s Laboratories Ltd.
- Bristol - Myers Squibb
- Pfizer Inc.
- Clinuvel Pharmaceuticals Ltd.
- Boston Pharmaceuticals
- Applied Biology, Inc.
- Arcutis Biotherapeutics, Inc.
- Villaris Therapeutics
- Arrien Pharmaceuticals LLC
- Temprian Therapeutics Inc.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Drug Type
  - Market Snapshot, By Indication Type
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter’s Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
Global 4D Printing Market, By Drug Type, 2021 – 2033, (USD Million)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022– 2033
  - Segment Trends
- Marketed Drug
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    - Calcineurin Inhibitors
    - Corticosteroids
    - Psoralens
- Pipeline Drug
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    - Ruxolitinib (Phase 3)
Global 4D Printing Market, By Indication Type, 2021 – 2033, (USD Million)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022– 2033
  - Segment Trends
- Segmental Vitiligo
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Non-segmental Vitiligo
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Global 4D Printing Market, By Route of Administration, 2021 – 2033, (USD Million)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022– 2033
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Topical
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Global 4D Printing Market, By Distribution Channel, 2021 – 2033, (USD Million)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022– 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Global 4D Printing Market, By Region, 2021 – 2033, (USD Million)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Regions, 2022–2033
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Material, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
  - Dermavant Sciences, Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Incyte Corporation
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Aclaris Therapeutics, Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Dr. Reddy’s Laboratories Ltd.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Bristol - Myers Squibb
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Pfizer Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Clinuvel Pharmaceuticals Ltd.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Boston Pharmaceuticals
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Applied Biology, Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Arcutis Biotherapeutics, Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Villaris Therapeutics
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Arrien Pharmaceuticals LLC
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Temprian Therapeutics Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
- Analyst Views
Section
- References
- Research Methodology
- About Us

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE